Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,648,000 | 5,172,000 | 4,897,000 | 7,289,000 | 8,015,000 |
| Marketable Securities | 0 | 244,000 | 331,000 | 772,000 | 770,000 |
| Receivables | 5,529,000 | 5,482,000 | 5,680,000 | 5,384,000 | 5,780,000 |
| Inventories | 1,929,000 | 1,895,000 | 1,702,000 | 1,605,000 | 1,786,000 |
| TOTAL | $20,166,000 | $15,100,000 | $14,413,000 | $16,945,000 | $18,465,000 |
| Non-Current Assets | |||||
| PPE Net | 2,894,000 | 2,879,000 | 2,860,000 | 2,883,000 | 2,950,000 |
| Investments And Advances | 131,000 | 1,473,000 | 1,477,000 | 1,420,000 | 1,463,000 |
| Intangibles | 34,573,000 | 36,101,000 | 36,452,000 | 36,896,000 | 42,343,000 |
| Other Non-Current Assets | 1,677,000 | 1,589,000 | 1,567,000 | 1,208,000 | 943,000 |
| TOTAL | $39,275,000 | $42,042,000 | $42,356,000 | $42,407,000 | $47,699,000 |
| Total Assets | $59,441,000 | $57,142,000 | $56,769,000 | $59,352,000 | $66,164,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,276,000 | 5,641,000 | 2,078,000 | 5,308,000 | 4,021,000 |
| Accounts payable and accrued liabilities | 12,217,000 | 11,300,000 | 11,826,000 | 11,931,000 | 11,366,000 |
| TOTAL | $17,493,000 | $16,941,000 | $13,904,000 | $17,239,000 | $15,387,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 33,126,000 | 31,619,000 | 35,066,000 | 35,002,000 | 36,487,000 |
| Other Non-Current Liabilities | 15,990,000 | 16,000,000 | 14,509,000 | 14,490,000 | 15,721,000 |
| TOTAL | $50,174,000 | $48,767,000 | $50,691,000 | $50,559,000 | $53,698,000 |
| Total Liabilities | $67,667,000 | $65,708,000 | $64,595,000 | $67,798,000 | $69,085,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,478,821 | 1,478,484 | 1,478,332 | 1,475,084 | 1,504,216 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 3,673,000 | 3,384,000 | 4,234,000 | 3,368,000 | 6,789,000 |
| Other shareholders' equity | -2,528,000 | -2,491,000 | -2,516,000 | -2,480,000 | -2,559,000 |
| TOTAL | $-8,226,000 | $-8,566,000 | $-7,826,000 | $-8,446,000 | $-2,921,000 |
| Total Liabilities And Equity | $59,441,000 | $57,142,000 | $56,769,000 | $59,352,000 | $66,164,000 |